Company: BA
Filing Date: 2025-03-07
Form Type: DEF 14A
Source: 0001193125-25-049921
Chunk: 38

Company: BOEING CO
Filing Date: 2025-03-07
Form: DEF 14A
Chunk 38
---
 according to Amendment No. 9 to the Schedule 13G filed by Vanguard with the SEC on February 13, 2024, the most recently available filing. Vanguard received an aggregate of approximately $187,000 for management fees in 2024 from a trust that funds a portion of our health and welfare plans. From time to time, we may enter into customary relationships and/or purchase services in the ordinary course of business from one or more of the financial institutions named above and/or their respective affiliates.

| 2025 Proxy Statement |     | 43 |

APPROVE, ON AN ADVISORY BASIS, NAMED EXECUTIVE OFFICER COMPENSATION (ITEM 2)

| PROPOSAL SUMMARY   Pursuant to Section 14A of the Securities Exchange Act of 1934, or the Exchange Act, shareholders are being asked to approve, on an advisory basis, the compensation of the named executive officers as set forth under the heading “Compensation Discussion and Analysis” and in the accompanying compensation tables and material. We expect that the next advisory vote on executive compensation will occur at our 2025 Annual Meeting of Shareholders. 
 The Board recommends that you vote FOR the resolution approving named executive officer compensation.                                                                                                                                                                                                                                                                                                                                                                          |     | To Our Shareholders:   We reaffirm our commitment to pay for performance, and our pay decisions and outcomes for 2024 reflect that commitment.   2024 was another extraordinarily challenging year for the Company. Following FAA and internal investigations of our production system in the wake of the 737-9 door plug accident on January 5, 2024, we slowed production rates and delayed rate increases as we implemented a comprehensive Safety & Quality Plan. These actions, taken to improve compliance with our manufacturing quality control requirements, significantly impacted our financial position and operating results in 2024, as compared to the challenging incentive plan goals we set for the Company at the start of the year. These negative impacts were compounded by the IAM 751 work stoppage that paused production of key commercial and commercial derivative programs for over two months, supply chain disruptions and continued challenges in our fixed-price development programs. Because our pay programs are aligned to Company performance, our incentive payouts reflect these poor financial and operational outcomes.   We continue to engage with and listen to our shareholders, and we took action throughout the year to respond to what we heard.   While our Board and this Committee have a long-standing practice of shareholder engagement, we took steps to accelerate and deepen the scope of these efforts immediately following